Related Experiment Video

Updated: Nov 19, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.9K

Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance

Ronay Cetin1, Eva Quandt2, Manuel Kaulich1,3,4

  • 1Institute of Biochemistry II, Goethe University Frankfurt-Medical Faculty, University Hospital, 60590 Frankfurt am Main, Germany.

Cells
|February 2, 2021
PubMed

Insights

Drug resistance in cancer leads to treatment failure. Gene perturbation technologies like RNA interference (RNAi) and CRISPR can identify new vulnerabilities linked to drug resistance, aiding clinical translation.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Drug resistance is a major cause of cancer treatment failure and relapse.
  • Resistance mechanisms can be intrinsic or acquired, leading to single-drug or multidrug resistance.
  • Cellular homeostasis alterations in drug-resistant cells can create unique vulnerabilities.

Purpose of the Study:

  • To explore how RNA interference (RNAi) and CRISPR technologies can discover drug resistance mechanisms.
  • To focus on vulnerabilities associated with first-line chemotherapy resistance.
  • To propose strategies for accelerating the clinical translation of these discoveries.

Main Methods:

  • Utilizing unbiased gene perturbation screens with RNAi and CRISPR technologies.
  • Applying these methods to cancer cell lines to identify genotype-to-phenotype relationships.
  • Analyzing resistance mechanisms in the context of first-line chemotherapy.

Main Results:

  • Gene perturbation screens are effective in uncovering resistance-coupled vulnerabilities.
  • These technologies facilitate genome-scale understanding of resistance mechanisms.
  • New vulnerabilities associated with specific drug resistance profiles have been identified.

Conclusions:

  • RNAi and CRISPR are powerful tools for discovering drug resistance mechanisms and vulnerabilities.
  • Understanding these vulnerabilities can lead to novel therapeutic strategies.
  • Accelerating clinical translation of these findings is crucial for improving cancer patient outcomes.
Keywords:
RNAi and CRISPR screenscancer and drug vulnerabilitieschemotherapy resistancefunctional genomics

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.4K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.0K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K